SCHEMBL13628507

SCHEMBL13628507

O=CC(O)c1cccc(O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 2/20 0.48
ADRA1A P35348 2/20 0.48
MIF P14174 1/20 0.48
HTR2A P28223 1/20 0.48
HTR2B P41595 1/20 0.48
LMNA P02545 5/20 0.47
HIF1A Q16665 4/20 0.47
GALR3 O60755 1/20 0.47
ADRB2 P07550 1/20 0.46
HTR1A P08908 1/20 0.46
ADRA2A P08913 1/20 0.46
ADRB3 P13945 1/20 0.46
TSHR P16473 1/20 0.46
ADRA2B P18089 1/20 0.46
ADRA2C P18825 1/20 0.46
NFKB1 P19838 1/20 0.46
DRD1 P21728 1/20 0.46
HTR7 P34969 1/20 0.46
ADRA1B P35368 1/20 0.46
DRD3 P35462 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7651096 0.79 ADRB1 (0.48) ADRB1ADRA1AMIFHTR2AHTR2B
SCHEMBL1723875 0.78 ESR1 (0.44) ADRB1ADRA1AMIFHTR2AHTR2B
SCHEMBL7192764 0.78 ADRB1 (0.52) ADRB1ADRA1AMIFHTR2AHTR2B
SCHEMBL1701121 0.78 ADRB1 (0.43) ADRB1ADRA1AMIFHTR2AHTR2B
SCHEMBL12648355 0.78 ADRB1 (0.52) ADRB1ADRA1AMIFHTR2AHTR2B
SCHEMBL7008264 0.78 ADRB1 (0.52) ADRB1ADRA1AMIFHTR2AHTR2B
SCHEMBL11279836 0.78 CES2 (0.51)
SCHEMBL8591942 0.78 ALDH1A1 (0.45) SLC6A3ALDH1A1CYP3A4
SCHEMBL1712223 0.78 ACP3 (0.47) ADRB1LMNAADRB3TSHRMEN1
SCHEMBL13585083 0.78 TYR (0.48) ADRB1ADRA1AMIFHTR2AHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622585-B2 Phenylglycinamide derivatives useful as anticoagulants BRISTOL-MYERS SQUIBB COMPANY (US) 2009-11-24 US disclosed
US-7456195-B2 Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants BRISTOL-MYERS SQUIBB COMPANY (US) 2008-11-25 US disclosed